Pasithea Therapeutics Corp. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pasithea Therapeutics Corp. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • Pasithea Therapeutics Corp. Return On Equity for the quarter ending June 30, 2024 was -74.6 %, a 80% decline year-over-year.
  • Pasithea Therapeutics Corp. annual Return On Equity for 2023 was -50.5 %, a 72.5% decline from 2022.
  • Pasithea Therapeutics Corp. annual Return On Equity for 2022 was -29.3 %, a 133% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -74.6 -33.2 -80% Apr 1, 2024 Jun 30, 2024
Q1 2024 -60.7 -25.4 -71.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -50.5 -21.2 -72.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -44 -27.6 -168% Jul 1, 2023 Sep 30, 2023
Q2 2023 -41.5 -29.4 -242% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.4 -24.6 -227% Jan 1, 2023 Mar 31, 2023
Q4 2022 -29.3 -16.7 -133% Oct 1, 2022 Dec 31, 2022
Q3 2022 -16.4 Jul 1, 2022 Sep 30, 2022
Q2 2022 -12.1 Apr 1, 2022 Jun 30, 2022
Q1 2022 -10.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -12.6 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.